Market Place
Sourcing Support
Bristol Myers Shifts Focus to AI Costs After Broad Worker Rollout
03 Jun 2026 //
ENDPOINTS
Bristol Myers turns focus to AI costs after broad rollout to work
03 Jun 2026 //
ENDPOINTS
FDA Grants Priority Review to Camzyos sNDA in oHCM Cardiomyopathy
01 Jun 2026 //
BUSINESSWIRE
BMS Wins EU Approval for Opdivo Plus AVD in Hodgkin Lymphoma
01 Jun 2026 //
BUSINESSWIRE
BioNTech/BMS and Pfizer Split on OS Approach in NSCLC IO Race
30 May 2026 //
FIERCE BIOTECH
BioNTech/BMS Pumitamig Shows Efficacy in NSCLC ROSETTA Trial
30 May 2026 //
GLOBENEWSWIRE
BMS Details Phase 3 Win for Pomalyst Successor at ASCO
29 May 2026 //
ENDPOINTS
Bristol Myers Squibb to Present at Goldman Sachs Conference
27 May 2026 //
BUSINESSWIRE
ADC Pipeline Debuts Data on Izalontamab Brengitecan at ASCO
22 May 2026 //
PR NEWSWIRE
Bristol Myers Squibb Unveils Broad Oncology Data at ASCO 2026
22 May 2026 //
PRESS RELEASE
Lilly, BMS, Incyte Strike Deals to Keep AI Momentum Rolling
22 May 2026 //
BIOSPACE
BMS Expands AI Integration System-Wide with Anthropic Claude
20 May 2026 //
FIERCE PHARMA
BMS looks at Houston for potential $1B manufacturing plant
18 May 2026 //
FIERCE PHARMA
BMS Partners With Tempus To Enhance Clinical Success With AI
15 May 2026 //
FIRSTWORD PHARMA
BMS, Hengrui Strike $15.2B Multi-Asset Pact
11 May 2026 //
FIERCE BIOTECH
BMS Wins EU Approval for Sotyktu in Active Psoriatic Arthritis
09 May 2026 //
PHARMIWEB
BMS Wins EU Approval for Sotyktu in Active Psoriatic Arthritis
08 May 2026 //
BUSINESSWIRE
BMS to Participate in BofA Securities Healthcare Conference 2026
06 May 2026 //
BUSINESSWIRE
BMS Launches Won`t Lose Campaign Ahead of FIFA World Cup 2026
04 May 2026 //
BUSINESSWIRE
Bristol Myers Sees Pivotal Year, AI Expansion Questioned
02 May 2026 //
ENDPOINTS
Bristol Myers Squibb Reports First Quarter 2026 Results
30 Apr 2026 //
BUSINESSWIRE
Bristol Myers Exceeds Profit Estimates With Strong Sales
30 Apr 2026 //
REUTERS
Krazati fails CRC trial; approval at risk
30 Apr 2026 //
ENDPOINTS
Analysts focus on 3 Programs in Big year for Bristol Myers
30 Apr 2026 //
ENDPOINTS
Bristol Myers Hits a Crossroads in a Make-or-Break Year
29 Apr 2026 //
ENDPOINTS
BMS, Pfizer Offer Eliquis Via Mark Cuban`s Cost Plus Drugs
24 Apr 2026 //
FIRSTWORD PHARMA
Atrium Therapeutics Nets $15M from BMS in Global CV Collaboration
23 Apr 2026 //
PR NEWSWIRE
Foundation Medicine, BMS Expand Deal for MTAP Deletion Dx
21 Apr 2026 //
BUSINESSWIRE
BMS layoffs hits Lawrenceville hard, adding 200+ to cut count
20 Apr 2026 //
BIOSPACE
BMS makes Beeline, bringing 5 assets to bio’s $300M Debut
16 Apr 2026 //
BIOSPACE
Oxford Biotherapeutics Collaborates With Bristol Myers Squibb
09 Apr 2026 //
GLOBENEWSWIRE
Boehringer Evaluates DLL3, PD-L1/VEGF-A Combo in SCLC
09 Apr 2026 //
GLOBENEWSWIRE
FDA Lifts Macrogenics Hold; Oxford And Bristol Myers Team Up
09 Apr 2026 //
ENDPOINTS
BMS Advances Equity in Multiple Myeloma Program at 10 Years
31 Mar 2026 //
BUSINESSWIRE
BMS Links Up With Faro To Use AI To Improve Trial Protocols
31 Mar 2026 //
FIERCE BIOTECH
BMS, Novartis, Gilead, Iovance Dinged In CBER Untitled Letters
30 Mar 2026 //
FIERCE PHARMA
BMS Camzyos Shows Ph3 Efficacy In Adolescent oHCM Trial
29 Mar 2026 //
BUSINESSWIRE
Takeda Clears Path To FDA With Phase 3 Data On $4B Psoriasis Bet
28 Mar 2026 //
FIERCE BIOTECH
Switch Study Shows Stability With Cobenfy In Patients
28 Mar 2026 //
PHARMIWEB
Insitro & BMS Collaboration Expanded with Nomination of Targets
23 Mar 2026 //
BUSINESSWIRE
Bristol Myers Squibb Strengthens Ohcm Leadership With Camzyos
23 Mar 2026 //
PHARMIWEB
FDA approves Bristol Myers`s cancer drug for Hodgkin`s lymphoma
20 Mar 2026 //
FDA
Bristol Myers Squibb To Report Results For First Quarter 2026
19 Mar 2026 //
BUSSINESSWIRE
BMS Brings Ashley Park Aboard Campaign Honoring Oncologists
18 Mar 2026 //
FIERCE PHARMA
FDA Expands Label For BMS` Sotyktu To Treat Psoriatic Arthritis
10 Mar 2026 //
FIERCE PHARMA
BMS` Celmod Drug Improves Myeloma PFS In Phase 3
09 Mar 2026 //
FIERCE BIOTECH
Bristol Myers Squibb Announces Dividend
02 Mar 2026 //
BUSINESSWIRE
BMS` ADC Hits Primary Endpoints In Phase 3 Breast Cancer Trial
27 Feb 2026 //
FIERCE BIOTECH
Evinova Secures AI Deals with Astellas, AstraZeneca
24 Feb 2026 //
FIERCE BIOTECH
BMS, Catalent Further Whittle Workforces
23 Feb 2026 //
BIOSPACE
BMS Announces Positive Results from Registrational Phase 2 Study
23 Feb 2026 //
PHARMIWEB
Bristol Myers Squibb Joins TD Cowen Health Care Conference
23 Feb 2026 //
BUSINESSWIRE
SC Clears Zydus to Sell Cancer Drug; BMS Told to Map Patents
11 Feb 2026 //
ECONOMICTIMES
AI Transforms Pharma`s Financials Beyond Drug Discovery
11 Feb 2026 //
BIOSPACE
BMS And Evinova Pen Global Development Partnership
09 Feb 2026 //
FIERCE BIOTECH
Evinova, Bristol Myers Squibb Partner To Enhance Clinical
09 Feb 2026 //
BUSINESSWIRE
BMS Beats Again Despite Eliquis And Cobenfy Disappointments
05 Feb 2026 //
BIOSPACE
BMS Turns Focus To New Growth Drivers As Legacy Meds Decline
05 Feb 2026 //
FIERCE PHARMA
OXB Inks Multi-Year Supply Deal With Bristol Myers Squibb
04 Feb 2026 //
GLOBENEWSWIRE
BMS Lauds Breyanzi`s Shutout Against Cancer With Soccer Legend
04 Feb 2026 //
FIERCE PHARMA
